3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
17
Melanoma
3
Glioma
3
Prostatic Neoplasms
2
Ovarian Neoplasms
2
Neoplasms
2
Neoplasm Metastasis
2
Multiple Endocrine Neoplasia Type 1
2
Diffuse Intrinsic Pontine Glioma
2
Thymus Neoplasms
1
Teratoma
1
Solid Tumors Harboring a BRAF V600 Mutation
1
Rhabdoid Tumor
1
Osteitis Deformans
1
Non functioning pancreatic endocrine tumor
1
Neuroendocrine Tumors
1
Neuroblastoma
1
Neoplasms, Germ Cell and Embryonal
1
Neoplasms by Site
1
Mesothelioma
1
Medulloblastoma
1
Lymphoma
1
Leukemia
1
Hematologic Neoplasms
1
Glioblastoma
1
Familial ependymoma
1
Fallopian Tube Neoplasms
1
Estrogen Receptor and/or Progesterone Receptor Positive
1
Cystadenocarcinoma, Serous
1
Carcinoma, Hepatocellular
1
Interventions
Doxorubicin
4
pazopanib
2
Ifosfamide
2
saracatinib
1
sapanisertib
1
indolepropanol phosphate
1
Watchful Waiting
1
TTI-621
1
Sunitinib
1
Razoxane
1
Radiotherapy, Intensity-Modulated
1
Radiotherapy, Conformal
1
Radiotherapy
1
Radiation
1
Polymerase Chain Reaction
1
Observation
1
Neoadjuvant Therapy
1
MLN 8237
1
Imatinib Mesylate
1
HhAntag691
1
Gene Expression Profiling
1
Dexrazoxane
1
Blotting, Western
1
Albumin-Bound Paclitaxel
1
2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide
1
130-nm albumin-bound paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Dermatofibrosarcoma
×
ribociclib
×
Clear all
No trials found.